Latest Breaking News On - Julia barnes weise - Page 2 : comparemela.com

Biden s waiver of vaccine patents helps, but it s not enough

Print The pharmaceutical industry, which thought it had entered the can-do-no-wrong stage of public esteem thanks to its development of COVID-19 vaccines in record time, just got taken down a peg by the Biden administration. On Wednesday, the administration said it supports waiving patent protections for those same vaccines to help combat the pandemic around the world. Drugmakers, which were counting on lavish profits from the vaccines, squealed like stuck pigs. Phrma, their leading trade group, called the policy “an unprecedented step that will undermine our global response to the pandemic and compromise safety.” This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures.

South africaUnited statesMichael hiltzikFrancis collinsAnthony fauciWilliam mossSantos rutschmanJulia barnes weiseKatherine taiDean bakerNational institutes of healthYork universityWorld trade organizationDefense departmentBiotechnology innovation organizationRepresentative katherine tai

Vaccine approvals offer hope as global Covid cases surge

By Anthony King, additional reporting by Bojan Stojkovski2021-01-14T16:35:00+00:00 As 2020 ended, news of the first Covid-19 vaccine approvals came as a huge relief to national governments and their citizens. Yet with Covid-19 infection rates rising in many countries, and with more infectious variants of the virus emerging, the need for widespread vaccination grows more urgent and regulators around the world are now racing to assess and approve vaccines. The BioNTech-Pfizer vaccine was first approved by the UK on 2 December and now has approval in almost 50 countries. Moderna’s vaccine also gained emergency approval in the US and the UK in December, with the European Medicines Agency (EMA) greenlighting it last week. Both are RNA vaccines and have shown efficacies of around 95% in their clinical trials.

New yorkUnited statesUnited kingdomUnited arab emiratesWorld health organizationAl qahirahJohn mooreDragan danilovskiJulia barnes weiseKim mulhollandPeter smithVenko filipceVaccine allianceWeill cornell medical collegeCoalition for epidemic preparedness innovationsEuropean union

With First Dibs on Vaccines, Rich Countries Have Cleared the Shelves But There s Some Good News for India

As a growing number of coronavirus vaccines advance through clinical trials, wealthy countries are fueling an extraordinary gap in access around the world, laying claim to more than half the doses that could come on the market by the end of next year. While many poor nations may be able to vaccinate at most 20% of their populations in 2021, some of the world’s richest countries have reserved enough doses to immunize their own multiple times over. With no guarantee that any particular vaccine would come through, these countries hedged their bets on a number of candidates. But if all the doses they have claimed are delivered, the European Union could inoculate its residents twice, Britain and the United States could do so four times over, and Canada six times over, according to a New York Times analysis of data on vaccine contracts collected by Duke University, UNICEF and Airfinity, a science analytics company.

New yorkUnited statesUnited kingdomSaudi arabiaUnited arab emiratesBruce aylwardRichard hatchettDonald trumpBill gatesAndrea taylorKendall hoytCarlos slimJoe bidenJulia barnes weiseErin otooleKrishna udayakumar

With first dibs on vaccines, rich countries have cleared the shelves

Megan Twohey, Keith Collins and Katie Thomas, The New York Times Published: 16 Dec 2020 01:05 AM BdST Updated: 16 Dec 2020 01:33 AM BdST Nathan Aamodt, left, documents Tim Ostgarden unload the COVID-19 vaccine at Sanford Health in Fargo, N.D., on Monday, Dec. 14, 2020. The first shots were given in the American mass vaccination campaign on Monday morning, opening a new chapter in the battle against the coronavirus pandemic, which has killed more people in the United States than in any other country.(Tim Gruber/The New York Times) As a growing number of coronavirus vaccines advance through clinical trials, wealthy countries are fuelling an extraordinary gap in access around the world, laying claim to more than half the doses that could come on the market by the end of next year.

New yorkUnited statesUnited kingdomSaudi arabiaUnited arab emiratesBruce aylwardRichard hatchettDonald trumpBill gatesAndrea taylorKendall hoytCarlos slimJoe bidenJulia barnes weiseErin otooleKrishna udayakumar

With first dibs on vaccines, rich countries have cleared the shelves - South Florida Sun Sentinel

With first dibs on vaccines, rich countries have cleared the shelves - South Florida Sun Sentinel
sun-sentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sun-sentinel.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomSaudi arabiaUnited arab emiratesBruce aylwardRichard hatchettDonald trumpBill gatesAndrea taylorKendall hoytCarlos slimJoe bidenJulia barnes weiseErin otooleKrishna udayakumar